179 related articles for article (PubMed ID: 36069231)
41. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
42. Meta-analysis of two computer-assisted screening methods for diagnosing oral precancer and cancer.
Ye X; Zhang J; Tan Y; Chen G; Zhou G
Oral Oncol; 2015 Nov; 51(11):966-975. PubMed ID: 26384539
[TBL] [Abstract][Full Text] [Related]
43. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches.
Sudbø J; Ried T; Bryne M; Kildal W; Danielsen H; Reith A
Oral Oncol; 2001 Oct; 37(7):558-65. PubMed ID: 11564576
[TBL] [Abstract][Full Text] [Related]
44. The Clinical Potential of Oral Microbiota as a Screening Tool for Oral Squamous Cell Carcinomas.
Zhou X; Hao Y; Peng X; Li B; Han Q; Ren B; Li M; Li L; Li Y; Cheng G; Li J; Ma Y; Zhou X; Cheng L
Front Cell Infect Microbiol; 2021; 11():728933. PubMed ID: 34485181
[TBL] [Abstract][Full Text] [Related]
45. Application of the Bethesda system of reporting for cervical cytology to evaluate human papilloma virus induced changes in oral leukoplakia, oral squamous cell carcinoma, and oropharyngeal squamous cell carcinoma: A cytomorphological and genetic study.
Sivakumar N; Narwal A; Kumar S; Kamboj M; Devi A; Pandiar D; Bhardwaj R
Diagn Cytopathol; 2021 Sep; 49(9):1036-1044. PubMed ID: 34165918
[TBL] [Abstract][Full Text] [Related]
46. A standalone approach to utilize telomere length measurement as a surveillance tool in oral leukoplakia.
Pal J; Rajput Y; Shrivastava S; Gahine R; Mungutwar V; Barardiya T; Chandrakar A; Ramakrishna PP; Mishra SS; Banjara H; Choudhary V; Patra PK; Shammas MA
Mol Oncol; 2022 Apr; 16(8):1650-1660. PubMed ID: 34725903
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
[TBL] [Abstract][Full Text] [Related]
48. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
49. Molecular screening of oral precancer.
Graveland AP; Bremmer JF; de Maaker M; Brink A; Cobussen P; Zwart M; Braakhuis BJ; Bloemena E; van der Waal I; Leemans CR; Brakenhoff RH
Oral Oncol; 2013 Dec; 49(12):1129-35. PubMed ID: 24120275
[TBL] [Abstract][Full Text] [Related]
50. Expression of PIWIL2 in oral cancer and leukoplakia: Prognostic implications and insights from tumors.
Wang S; Li F; Fan H; Xu J; Hu Z
Cancer Biomark; 2019; 26(1):11-20. PubMed ID: 31322538
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity--a prospective and blinded study.
Koch FP; Kunkel M; Biesterfeld S; Wagner W
Clin Oral Investig; 2011 Oct; 15(5):763-9. PubMed ID: 20593209
[TBL] [Abstract][Full Text] [Related]
52. Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report.
Jeong AR; Forbes K; Orosco RK; Cohen EEW
J Otolaryngol Head Neck Surg; 2022 Feb; 51(1):5. PubMed ID: 35123577
[TBL] [Abstract][Full Text] [Related]
53. Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining.
de Boer DV; Brink A; Buijze M; Stigter-van Walsum M; Hunter KD; Ylstra B; Bloemena E; Leemans CR; Brakenhoff RH
Mol Cancer Res; 2019 Jan; 17(1):120-130. PubMed ID: 30224542
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.
Miller CS; Johnstone BM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):622-35. PubMed ID: 11402272
[TBL] [Abstract][Full Text] [Related]
55. Validation of methylation markers for diagnosis of oral cavity cancer.
Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of nucleolar organizer regions (AgNORs) in brush biopsies of suspicious lesions of the oral cavity.
Remmerbach TW; Weidenbach H; Müller C; Hemprich A; Pomjanski N; Buckstegge B; Böcking A
Anal Cell Pathol; 2003; 25(3):139-46. PubMed ID: 12775918
[TBL] [Abstract][Full Text] [Related]
57. Real Time Optical Vascular Imaging: A Potential Technique for the Diagnosis of Mucosal Disease Including Early Oral Cancer.
Bastos P; Cook R
Prim Dent J; 2016 Feb; 5(1):86-91. PubMed ID: 29029659
[TBL] [Abstract][Full Text] [Related]
58. The Diagnostic Role of Methyl Green-Pyronin Y Staining in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Exfoliative Cytology-Based Cytomorphometric Analysis.
Raman RK; Kamboj M; Narwal A
Acta Cytol; 2019; 63(5):401-410. PubMed ID: 31112943
[TBL] [Abstract][Full Text] [Related]
59. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma.
Haya-Fernández MC; Bagán JV; Murillo-Cortés J; Poveda-Roda R; Calabuig C
Oral Dis; 2004 Nov; 10(6):346-8. PubMed ID: 15533209
[TBL] [Abstract][Full Text] [Related]
60. Cytologic and DNA-cytometric early diagnosis of oral cancer.
Remmerbach TW; Weidenbach H; Pomjanski N; Knops K; Mathes S; Hemprich A; Böcking A
Anal Cell Pathol; 2001; 22(4):211-21. PubMed ID: 11564897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
